Analysts' Actions -- Chemours, Incyte, Visteon, Toyota and More

RATINGS CHANGES

Chemours (CC) was upgraded to overweight and assigned a $50 price target at JPMorgan. 

GW Pharmaceuticals (GWPH) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: GWPH.

Incyte (INCY) was initiated with a market perform rating and assigned a $125 price target at Oppenheimer. 

Paycom Software (PAYC) was initiated with an outperform rating and $75 price target at Wells Fargo. 

Toyota Motor TM was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: TM.

Ultimate Software (ULTI) was initiated with an outperform rating and $240 price target at Wells Fargo. 

Uni-Pixel (UNXL) was downgraded to neutral and assigned a $0.45 price target at Roth Capital. 

Visteon (VC) was upgraded to overweight at Morgan Stanley and assigned a $115 price target. 

Westlake (WLK) was upgraded to buy and assigned a $71 price target at Tudor Pickering. 

This article was written by a staff member of TheStreet.

More from Stocks

Jim Cramer on What's Next for U.S.-China Trade Relations

Jim Cramer on What's Next for U.S.-China Trade Relations

Jim Cramer: China Trade Tensions Make it Tougher to Pick Stocks

Jim Cramer: China Trade Tensions Make it Tougher to Pick Stocks

Lee Munson Discusses the Market and Areas of Opportunity for Investors

Lee Munson Discusses the Market and Areas of Opportunity for Investors

Jim Cramer on Larry Kudlow, Tariffs, Nucor, IBM and Domino's Pizza

Jim Cramer on Larry Kudlow, Tariffs, Nucor, IBM and Domino's Pizza

Dow Falls on Trade Worries but IBM Rises as Earnings Beat Forecasts

Dow Falls on Trade Worries but IBM Rises as Earnings Beat Forecasts